According to Healthequity, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 12:42 PM, company Director, Corvino Frank disclosed selling 7,403 shares at a cost of $75.79. At the time of this transaction (Jan 08), this trade was worth $561,079 in total. As of Jan […]
According to Chemed Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 11:48 AM, company president and CEO, Mcnamara Kevin J disclosed selling 2,000 shares at a cost of $549.30. At the time of this transaction (Jan 08), this trade was worth $1,098,600 in total. […]
According to Fs Bancorp, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 10:44 AM, company Director, Tueffers Mark disclosed selling 423 shares at a cost of $60.00. At the time of this transaction (Jan 08), this trade was worth $25,381 in total. As of […]
According to Atlantic Capital Bancshares, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 10:39 AM, company CHIEF CREDIT OFFICER, Bugbee Robert R Ii disclosed selling 1,000 shares at a cost of $16.85. At the time of this transaction (Jan 08), this trade was worth […]
According to World Fuel Services Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 09:31 AM, company Director, Stebbins Paul H disclosed selling 38,414 shares at a cost of $33.48. At the time of this transaction (Jan 07), this trade was worth $1,286,101 in total. […]
According to World Fuel Services Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 09:31 AM, company Director, Stebbins Paul H disclosed selling 11,586 shares at a cost of $33.29. At the time of this transaction (Jan 06), this trade was worth $385,698 in total. […]
According to Jounce Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 06:21 AM, company Chief Medical Officer, Trehu Elizabeth disclosed selling 2,846 shares at a cost of $7.00. At the time of this transaction (Jan 08), this trade was worth $19,922 in total. […]
According to Jounce Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 06:21 AM, company Chief Medical Officer, Trehu Elizabeth disclosed selling 2,452 shares at a cost of $6.76. At the time of this transaction (Jan 07), this trade was worth $16,576 in total. […]
According to Jounce Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 06:21 AM, company CEO and President, Murray Richard /Ca/ disclosed selling 11,816 shares at a cost of $7.00. At the time of this transaction (Jan 08), this trade was worth $82,712 in […]
According to Jounce Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 11 06:21 AM, company CEO and President, Murray Richard /Ca/ disclosed selling 10,183 shares at a cost of $6.76. At the time of this transaction (Jan 07), this trade was worth $68,837 in […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
